163 related articles for article (PubMed ID: 25888905)
1. Candesartan restores pressure-induced vasodilation and prevents skin pressure ulcer formation in diabetic mice.
Danigo A; Nasser M; Bessaguet F; Javellaud J; Oudart N; Achard JM; Demiot C
Cardiovasc Diabetol; 2015 Feb; 14():26. PubMed ID: 25888905
[TBL] [Abstract][Full Text] [Related]
2. Erythropoietin restores C-fiber function and prevents pressure ulcer formation in diabetic mice.
Demiot C; Sarrazy V; Javellaud J; Gourloi L; Botelle L; Oudart N; Achard JM
J Invest Dermatol; 2011 Nov; 131(11):2316-22. PubMed ID: 21833012
[TBL] [Abstract][Full Text] [Related]
3. Protective mechanisms of the angiotensin II type 1 receptor blocker candesartan against cerebral ischemia: in-vivo and in-vitro studies.
Liu H; Kitazato KT; Uno M; Yagi K; Kanematsu Y; Tamura T; Tada Y; Kinouchi T; Nagahiro S
J Hypertens; 2008 Jul; 26(7):1435-45. PubMed ID: 18551021
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II type 1 receptor blocker attenuates diabetes-induced atrial structural remodeling.
Kato T; Yamashita T; Sekiguchi A; Tsuneda T; Sagara K; Takamura M; Kaneko S; Aizawa T; Fu LT
J Cardiol; 2011 Sep; 58(2):131-6. PubMed ID: 21802905
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II receptor blocker provides pancreatic beta-cell protection independent of blood pressure lowering in diabetic db/db mice.
Shao JQ; Iwashita N; Du H; Wang YT; Wang YY; Zhao M; Wang J; Watada H; Kawamori R
Acta Pharmacol Sin; 2007 Feb; 28(2):246-57. PubMed ID: 17241528
[TBL] [Abstract][Full Text] [Related]
6. Candesartan improves memory decline in mice: involvement of AT1 receptors in memory deficit induced by intracerebral streptozotocin.
Tota S; Kamat PK; Awasthi H; Singh N; Raghubir R; Nath C; Hanif K
Behav Brain Res; 2009 May; 199(2):235-40. PubMed ID: 19103228
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II and endothelin-1 augment the vascular complications of diabetes via JAK2 activation.
Banes-Berceli AK; Ketsawatsomkron P; Ogbi S; Patel B; Pollock DM; Marrero MB
Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H1291-9. PubMed ID: 17526654
[TBL] [Abstract][Full Text] [Related]
8. Preservation of pressure-induced cutaneous vasodilation by limiting oxidative stress in short-term diabetic mice.
Demiot C; Fromy B; Saumet JL; Sigaudo-Roussel D
Cardiovasc Res; 2006 Jan; 69(1):245-52. PubMed ID: 16266692
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II type 1 receptor blocker attenuates myocardial remodeling and preserves diastolic function in diabetic heart.
Tsutsui H; Matsushima S; Kinugawa S; Ide T; Inoue N; Ohta Y; Yokota T; Hamaguchi S; Sunagawa K
Hypertens Res; 2007 May; 30(5):439-49. PubMed ID: 17587756
[TBL] [Abstract][Full Text] [Related]
10. Role of AT1 receptors in permeability of the blood-brain barrier in diabetic hypertensive rats.
Awad AS
Vascul Pharmacol; 2006 Sep; 45(3):141-7. PubMed ID: 16959546
[TBL] [Abstract][Full Text] [Related]
11. Restoration of diabetes-induced abnormal local Ca2+ release in cardiomyocytes by angiotensin II receptor blockade.
Yaras N; Bilginoglu A; Vassort G; Turan B
Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H912-20. PubMed ID: 17012347
[TBL] [Abstract][Full Text] [Related]
12. Protection against oxidative stress in diabetic rats: role of angiotensin AT(1) receptor and beta 1-adrenoceptor antagonism.
Dorenkamp M; Riad A; Stiehl S; Spillmann F; Westermann D; Du J; Pauschinger M; Noutsias M; Adams V; Schultheiss HP; Tschöpe C
Eur J Pharmacol; 2005 Sep; 520(1-3):179-87. PubMed ID: 16139267
[TBL] [Abstract][Full Text] [Related]
13. [Effects of angiotensin II type 1 receptor blocker on islet of diabetic db/db mice].
Shao JQ; Iwashita N; Du H; Wang YY; Zhao M; Wang J; Watada H; Kawamori R
Zhonghua Nei Ke Za Zhi; 2007 Apr; 46(4):306-10. PubMed ID: 17637271
[TBL] [Abstract][Full Text] [Related]
14. The pleiotropic actions of rosuvastatin confer renal benefits in the diabetic Apo-E knockout mouse.
Giunti S; Calkin AC; Forbes JM; Allen TJ; Thomas MC; Cooper ME; Jandeleit-Dahm KA
Am J Physiol Renal Physiol; 2010 Sep; 299(3):F528-35. PubMed ID: 20554645
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effects of candesartan, an angiotensin II type 1 receptor blocker, on beta-cell function and morphology in db/db mice.
Shao J; Iwashita N; Ikeda F; Ogihara T; Uchida T; Shimizu T; Uchino H; Hirose T; Kawamori R; Watada H
Biochem Biophys Res Commun; 2006 Jun; 344(4):1224-33. PubMed ID: 16650382
[TBL] [Abstract][Full Text] [Related]
16. Azilsartan, an angiotensin II type 1 receptor blocker, restores endothelial function by reducing vascular inflammation and by increasing the phosphorylation ratio Ser(1177)/Thr(497) of endothelial nitric oxide synthase in diabetic mice.
Matsumoto S; Shimabukuro M; Fukuda D; Soeki T; Yamakawa K; Masuzaki H; Sata M
Cardiovasc Diabetol; 2014 Jan; 13():30. PubMed ID: 24485356
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of mineralocorticoid receptor blockade against neuropathy in experimental diabetic rats.
Takata H; Takeda Y; Zhu A; Cheng Y; Yoneda T; Demura M; Yagi K; Karashima S; Yamagishi M
Diabetes Obes Metab; 2012 Feb; 14(2):155-62. PubMed ID: 21951301
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II receptor blockers improve endothelial dysfunction associated with sympathetic hyperactivity in metabolic syndrome.
Kishi T; Hirooka Y; Konno S; Sunagawa K
J Hypertens; 2012 Aug; 30(8):1646-55. PubMed ID: 22728908
[TBL] [Abstract][Full Text] [Related]
19. Aldose reductase pathway inhibition improved vascular and C-fiber functions, allowing for pressure-induced vasodilation restoration during severe diabetic neuropathy.
Demiot C; Tartas M; Fromy B; Abraham P; Saumet JL; Sigaudo-Roussel D
Diabetes; 2006 May; 55(5):1478-83. PubMed ID: 16644708
[TBL] [Abstract][Full Text] [Related]
20. Pleiotropic Benefits of the Angiotensin Receptor Blocker Candesartan in a Mouse Model of Alzheimer Disease.
Trigiani LJ; Royea J; Lacalle-Aurioles M; Tong XK; Hamel E
Hypertension; 2018 Nov; 72(5):1217-1226. PubMed ID: 30354809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
